Cundy T et al. |
A mutation in the gene TNFRSF11B encoding osteoprotegerin causes an idiopathic hyperphosphatasia phenotype. |
2002 |
Hum. Mol. Genet. |
pmid:12189164
|
Williamson E et al. |
Regulation of mucosal dendritic cell function by receptor activator of NF-kappa B (RANK)/RANK ligand interactions: impact on tolerance induction. |
2002 |
J. Immunol. |
pmid:12244151
|
Lee SK et al. |
1,25(OH)2 vitamin D3-stimulated osteoclast formation in spleen-osteoblast cocultures is mediated in part by enhanced IL-1 alpha and receptor activator of NF-kappa B ligand production in osteoblasts. |
2002 |
J. Immunol. |
pmid:12193704
|
Ferrer Cañabate J et al. |
[Osteoprotegrin and RANKL/RANK system: is it the future of bone metabolism?]. |
2002 |
An Med Interna |
pmid:12244784
|
Chen XW et al. |
Isoflavones regulate interleukin-6 and osteoprotegerin synthesis during osteoblast cell differentiation via an estrogen-receptor-dependent pathway. |
2002 |
Biochem. Biophys. Res. Commun. |
pmid:12150965
|
Katagiri T and Takahashi N |
Regulatory mechanisms of osteoblast and osteoclast differentiation. |
2002 |
Oral Dis |
pmid:12108759
|
Lee SK and Lorenzo JA |
Regulation of receptor activator of nuclear factor-kappa B ligand and osteoprotegerin mRNA expression by parathyroid hormone is predominantly mediated by the protein kinase a pathway in murine bone marrow cultures. |
2002 |
Bone |
pmid:12110442
|
Shioi A et al. |
Induction of bone-type alkaline phosphatase in human vascular smooth muscle cells: roles of tumor necrosis factor-alpha and oncostatin M derived from macrophages. |
2002 |
Circ. Res. |
pmid:12114316
|
Granchi D et al. |
Bone cement extracts modulate the osteoprotegerin/osteoprotegerin-ligand expression in MG63 osteoblast-like cells. |
2002 |
Biomaterials |
pmid:12013183
|
Li X et al. |
Prostaglandin receptor EP2 mediates PGE2 stimulated hypercalcemia in mice in vivo. |
2002 |
Prostaglandins Other Lipid Mediat. |
pmid:12013525
|
Bosshart H |
Expression of survival receptors in Hodgkin disease cell lines. |
2002 |
Blood |
pmid:12001908
|
Ono K et al. |
Involvement of cyclo-oxygenase-2 in osteoclast formation and bone destruction in bone metastasis of mammary carcinoma cell lines. |
2002 |
J. Bone Miner. Res. |
pmid:12009007
|
Iida-Klein A et al. |
Anabolic action of parathyroid hormone is skeletal site specific at the tissue and cellular levels in mice. |
2002 |
J. Bone Miner. Res. |
pmid:12009011
|
Jain RG and Lenhard JM |
Select HIV protease inhibitors alter bone and fat metabolism ex vivo. |
2002 |
J. Biol. Chem. |
pmid:11937496
|
Rogers A et al. |
Circulating estradiol and osteoprotegerin as determinants of bone turnover and bone density in postmenopausal women. |
2002 |
J. Clin. Endocrinol. Metab. |
pmid:12364420
|
Romas E et al. |
Osteoprotegerin reduces osteoclast numbers and prevents bone erosion in collagen-induced arthritis. |
2002 |
Am. J. Pathol. |
pmid:12368214
|
Standal T et al. |
Osteoprotegerin is bound, internalized, and degraded by multiple myeloma cells. |
2002 |
Blood |
pmid:12351414
|
Yang SY et al. |
Adeno-associated virus-mediated osteoprotegerin gene transfer protects against particulate polyethylene-induced osteolysis in a murine model. |
2002 |
Arthritis Rheum. |
pmid:12355500
|
Cremer I et al. |
Long-lived immature dendritic cells mediated by TRANCE-RANK interaction. |
2002 |
Blood |
pmid:12393586
|
Giuliani N et al. |
Human myeloma cells stimulate the receptor activator of nuclear factor-kappa B ligand (RANKL) in T lymphocytes: a potential role in multiple myeloma bone disease. |
2002 |
Blood |
pmid:12393684
|
Liao EY et al. |
Comparison of the effects of 17beta-E2 and progesterone on the expression of osteoprotegerin in normal human osteoblast-like cells. |
2002 |
J. Endocrinol. Invest. |
pmid:12398237
|
Kazama JJ et al. |
Circulating osteoprotegerin is not removed through haemodialysis membrane. |
2002 |
Nephrol. Dial. Transplant. |
pmid:12271009
|
Lee SW et al. |
TAK1-dependent activation of AP-1 and c-Jun N-terminal kinase by receptor activator of NF-kappaB. |
2002 |
J. Biochem. Mol. Biol. |
pmid:12296995
|
Redlich K et al. |
Tumor necrosis factor alpha-mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin. |
2002 |
Arthritis Rheum. |
pmid:11920416
|
Yang X et al. |
Protein Kinase C is a mediator of the synthesis and secretion of osteoprotegerin in osteoblast-like cells. |
2002 |
Biochem. Biophys. Res. Commun. |
pmid:11779130
|
Saidenberg Kermanac'h N et al. |
Osteoprotegerin and inflammation. |
2002 Apr-Jun |
Eur. Cytokine Netw. |
pmid:12101070
|
Jung K et al. |
Osteoprotegerin and receptor activator of nuclear factor-kappaB ligand (RANKL) in the serum of healthy adults. |
2002 Jul-Sep |
Int. J. Biol. Markers |
pmid:12408468
|
Liu JZ et al. |
[Expression of human osteoprotegerin gene in E. Coli and bioactivity analysis of expression product]. |
2003 |
Zhonghua Wai Ke Za Zhi |
pmid:14680558
|
Yamada Y et al. |
Association of polymorphisms of the osteoprotegerin gene with bone mineral density in Japanese women but not men. |
2003 |
Mol. Genet. Metab. |
pmid:14680982
|
Nakatsuka K et al. |
Phenotypic characterization of early onset Paget's disease of bone caused by a 27-bp duplication in the TNFRSF11A gene. |
2003 |
J. Bone Miner. Res. |
pmid:12929927
|
Li JP and Ling JQ |
[Tumor necrosis factor and lipopolysaccharide affect periodontal ligament cells expressing osteoprotegerin in vitro]. |
2003 |
Zhonghua Kou Qiang Yi Xue Za Zhi |
pmid:12930661
|
Schett G et al. |
The role of osteoprotegerin in arthritis. |
2003 |
Arthritis Res. Ther. |
pmid:12932284
|
Stilgren LS et al. |
Osteoprotegerin levels in primary hyperparathyroidism: effect of parathyroidectomy and association with bone metabolism. |
2003 |
Calcif. Tissue Int. |
pmid:14667132
|
Karsdal MA et al. |
Transforming growth factor-beta controls human osteoclastogenesis through the p38 MAPK and regulation of RANK expression. |
2003 |
J. Biol. Chem. |
pmid:12933809
|
Okada T et al. |
Bone marrow metastatic myeloma cells promote osteoclastogenesis through RANKL on endothelial cells. |
2003 |
Clin. Exp. Metastasis |
pmid:14669795
|
Benevolenskaia LI |
[Issues of osteoporosis in present-day medicine]. |
2003 |
Vestn. Akad. Med. Nauk SSSR |
pmid:12934464
|
Gannagé-Yared MH et al. |
Effects of a short-term calcium and vitamin D treatment on serum cytokines, bone markers, insulin and lipid concentrations in healthy post-menopausal women. |
2003 |
J. Endocrinol. Invest. |
pmid:14669830
|
Sugatani T et al. |
Activin A stimulates IkappaB-alpha/NFkappaB and RANK expression for osteoclast differentiation, but not AKT survival pathway in osteoclast precursors. |
2003 |
J. Cell. Biochem. |
pmid:12938156
|
Ashcroft AJ et al. |
Colonic dendritic cells, intestinal inflammation, and T cell-mediated bone destruction are modulated by recombinant osteoprotegerin. |
2003 |
Immunity |
pmid:14670302
|
Min JK et al. |
Vascular endothelial growth factor up-regulates expression of receptor activator of NF-kappa B (RANK) in endothelial cells. Concomitant increase of angiogenic responses to RANK ligand. |
2003 |
J. Biol. Chem. |
pmid:12893832
|
Chong B et al. |
Idiopathic hyperphosphatasia and TNFRSF11B mutations: relationships between phenotype and genotype. |
2003 |
J. Bone Miner. Res. |
pmid:14672344
|
Teitelbaum SL and Ross FP |
Genetic regulation of osteoclast development and function. |
2003 |
Nat. Rev. Genet. |
pmid:12897775
|
Si AI et al. |
Expression and localization of extracellular matrix metalloproteinase inducer in giant cell tumor of bone. |
2003 |
J. Cell. Biochem. |
pmid:12898514
|
Nitta K et al. |
The progression of vascular calcification and serum osteoprotegerin levels in patients on long-term hemodialysis. |
2003 |
Am. J. Kidney Dis. |
pmid:12900812
|
Fizazi K et al. |
Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts. |
2003 |
Clin. Cancer Res. |
pmid:12855635
|
Sezer O et al. |
RANK ligand and osteoprotegerin in myeloma bone disease. |
2003 |
Blood |
pmid:12424190
|
Yamada T et al. |
Regulation of osteoclast development by Notch signaling directed to osteoclast precursors and through stromal cells. |
2003 |
Blood |
pmid:12411305
|
Smith MD et al. |
Microarchitecture and protective mechanisms in synovial tissue from clinically and arthroscopically normal knee joints. |
2003 |
Ann. Rheum. Dis. |
pmid:12634226
|
Sakurai A et al. |
Streptococcus pyogenes infection induces septic arthritis with increased production of the receptor activator of the NF-kappaB ligand. |
2003 |
Infect. Immun. |
pmid:14500523
|
Kim HH et al. |
RANKL regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. |
2003 |
FASEB J. |
pmid:14500543
|
Su X et al. |
[The effects of 17 beta-estradiol on the expression of osteoprotegerin, the ligand of osteoprotegerin and related cytokines in osteosarcoma MG63 cells]. |
2003 |
Zhonghua Nei Ke Za Zhi |
pmid:14636471
|
Takayanagi H |
[Crosstalk between the immune and skeletal system]. |
2003 |
Ryumachi |
pmid:14598653
|
Cho TJ et al. |
Tumor necrosis factor alpha activation of the apoptotic cascade in murine articular chondrocytes is associated with the induction of metalloproteinases and specific pro-resorptive factors. |
2003 |
Arthritis Rheum. |
pmid:14558090
|
von Tirpitz C et al. |
Effect of systemic glucocorticoid therapy on bone metabolism and the osteoprotegerin system in patients with active Crohn's disease. |
2003 |
Eur J Gastroenterol Hepatol |
pmid:14560148
|
Kido S et al. |
Expression of RANK is dependent upon differentiation into the macrophage/osteoclast lineage: induction by 1alpha,25-dihydroxyvitamin D3 and TPA in a human myelomonocytic cell line, HL60. |
2003 |
Bone |
pmid:12810169
|
Barillé-Nion S and Bataille R |
New insights in myeloma-induced osteolysis. |
2003 |
Leuk. Lymphoma |
pmid:14565645
|
Kudlacek S et al. |
Serum levels of osteoprotegerin increase with age in a healthy adult population. |
2003 |
Bone |
pmid:12810175
|
Mandelin J et al. |
Imbalance of RANKL/RANK/OPG system in interface tissue in loosening of total hip replacement. |
2003 |
J Bone Joint Surg Br |
pmid:14653607
|
Ikeda T et al. |
Hepatocellular carcinoma with osteoclast-like giant cells: possibility of osteoclastogenesis by hepatocyte-derived cells. |
2003 |
Pathol. Int. |
pmid:12828610
|
Malyszko J et al. |
Osteoprotegerin and its correlations with new markers of bone formation and bone resorption in kidney transplant recipients. |
2003 |
Transplant. Proc. |
pmid:14529897
|
Crotti T et al. |
Receptor activator NF kappaB ligand (RANKL) and osteoprotegerin (OPG) protein expression in periodontitis. |
2003 |
J. Periodont. Res. |
pmid:12828654
|
Ren W et al. |
Distinct gene expression of receptor activator of nuclear factor-kappaB and rank ligand in the inflammatory response to variant morphologies of UHMWPE particles. |
2003 |
Biomaterials |
pmid:14530078
|
Tazoe M et al. |
Involvement of p38MAP kinase in bone morphogenetic protein-4-induced osteoprotegerin in mouse bone-marrow-derived stromal cells. |
2003 |
Arch. Oral Biol. |
pmid:12828991
|
Wiethe C et al. |
Enhanced effector and memory CTL responses generated by incorporation of receptor activator of NF-kappa B (RANK)/RANK ligand costimulatory molecules into dendritic cell immunogens expressing a human tumor-specific antigen. |
2003 |
J. Immunol. |
pmid:14530334
|
Wiethe C et al. |
Provision of 4-1BB ligand enhances effector and memory CTL responses generated by immunization with dendritic cells expressing a human tumor-associated antigen. |
2003 |
J. Immunol. |
pmid:12626542
|
Wagner EF and Matsuo K |
Signalling in osteoclasts and the role of Fos/AP1 proteins. |
2003 |
Ann. Rheum. Dis. |
pmid:14532157
|
Ueland T et al. |
Age-related changes in cortical bone content of insulin-like growth factor binding protein (IGFBP)-3, IGFBP-5, osteoprotegerin, and calcium in postmenopausal osteoporosis: a cross-sectional study. |
2003 |
J. Clin. Endocrinol. Metab. |
pmid:12629078
|
Ueland T et al. |
Growth hormone substitution increases gene expression of members of the IGF family in cortical bone from women with adult onset growth hormone deficiency--relationship with bone turn-over. |
2003 |
Bone |
pmid:14555269
|
Schoppet M et al. |
Increased osteoprotegerin serum levels in men with coronary artery disease. |
2003 |
J. Clin. Endocrinol. Metab. |
pmid:12629080
|
Han W et al. |
Construction of a new tumour necrosis factor fusion-protein expression vector for high-level expression of heterologous genes in Escherichia coli. |
2003 |
Biotechnol. Appl. Biochem. |
pmid:12630898
|
Koshihara Y et al. |
Vitamin K stimulates osteoblastogenesis and inhibits osteoclastogenesis in human bone marrow cell culture. |
2003 |
J. Endocrinol. |
pmid:12630919
|
Alvarez L et al. |
Serum osteoprotegerin and its ligand in Paget's disease of bone: relationship to disease activity and effect of treatment with bisphosphonates. |
2003 |
Arthritis Rheum. |
pmid:12632438
|
Cheung J et al. |
Interleukin-6 (IL-6), IL-1, receptor activator of nuclear factor kappaB ligand (RANKL) and osteoprotegerin production by human osteoblastic cells: comparison of the effects of 17-beta oestradiol and raloxifene. |
2003 |
J. Endocrinol. |
pmid:12773123
|
Nakamura H et al. |
Suppression of osteoblastic phenotypes and modulation of pro- and anti-apoptotic features in normal human osteoblastic cells under a vector-averaged gravity condition. |
2003 |
J. Med. Dent. Sci. |
pmid:12968638
|
Viereck V et al. |
Raloxifene concurrently stimulates osteoprotegerin and inhibits interleukin-6 production by human trabecular osteoblasts. |
2003 |
J. Clin. Endocrinol. Metab. |
pmid:12970288
|
Yamagami H et al. |
Inhibition of osteoclastogenesis by a phosphodiesterase 4 inhibitor XT-611 through synergistic action with endogenous prostaglandin E2. |
2003 |
Biochem. Pharmacol. |
pmid:12948861
|
Srivastava S et al. |
Receptor activator of NF-kappaB ligand induction via Jak2 and Stat5a in mammary epithelial cells. |
2003 |
J. Biol. Chem. |
pmid:12952963
|
Lee HA et al. |
Bumetanide, the specific inhibitor of Na+-K+-2Cl- cotransport, inhibits 1alpha,25-dihydroxyvitamin D3-induced osteoclastogenesis in a mouse co-culture system. |
2003 |
Exp. Physiol. |
pmid:12955156
|
Yorke R et al. |
Receptor activator of nuclear factor kappaB (RANK) is expressed as a late event during malignant progression in Barrett's metaplasia. |
2003 |
Eur. J. Cancer |
pmid:12957466
|
Kaneyama K et al. |
Expression of osteoprotegerin in synovial tissue and degradation of articular cartilage: comparison with arthroscopic findings of temporomandibular joint disorders. |
2003 |
Oral Surg Oral Med Oral Pathol Oral Radiol Endod |
pmid:12973279
|
Lee ZH and Kim HH |
Signal transduction by receptor activator of nuclear factor kappa B in osteoclasts. |
2003 |
Biochem. Biophys. Res. Commun. |
pmid:12745060
|
Boyle WJ et al. |
Osteoclast differentiation and activation. |
2003 |
Nature |
pmid:12748652
|
Terpos E et al. |
Soluble receptor activator of nuclear factor kappaB ligand-osteoprotegerin ratio predicts survival in multiple myeloma: proposal for a novel prognostic index. |
2003 |
Blood |
pmid:12689925
|
Zheng B et al. |
MEK/ERK pathway is aberrantly active in Hodgkin disease: a signaling pathway shared by CD30, CD40, and RANK that regulates cell proliferation and survival. |
2003 |
Blood |
pmid:12689928
|
Clohisy D |
Cellular mechanisms of osteolysis. |
2003 |
J Bone Joint Surg Am |
pmid:12540662
|
Vanderkerken K et al. |
Recombinant osteoprotegerin decreases tumor burden and increases survival in a murine model of multiple myeloma. |
2003 |
Cancer Res. |
pmid:12543775
|
Yu Q et al. |
Cooperation of TNF family members CD40 ligand, receptor activator of NF-kappa B ligand, and TNF-alpha in the activation of dendritic cells and the expansion of viral specific CD8+ T cell memory responses in HIV-1-infected and HIV-1-uninfected individuals. |
2003 |
J. Immunol. |
pmid:12574344
|
Rifas L et al. |
Inflammatory T cells rapidly induce differentiation of human bone marrow stromal cells into mature osteoblasts. |
2003 |
J. Cell. Biochem. |
pmid:12577299
|
Gordeladze JO and Reseland JE |
A unified model for the action of leptin on bone turnover. |
2003 |
J. Cell. Biochem. |
pmid:12577304
|
Lubberts E et al. |
IL-17 promotes bone erosion in murine collagen-induced arthritis through loss of the receptor activator of NF-kappa B ligand/osteoprotegerin balance. |
2003 |
J. Immunol. |
pmid:12594294
|
Kato I et al. |
TRANCE together with IL-7 induces pre-B cells to proliferate. |
2003 |
Eur. J. Immunol. |
pmid:12548564
|
Sordillo EM and Pearse RN |
RANK-Fc: a therapeutic antagonist for RANK-L in myeloma. |
2003 |
Cancer |
pmid:12548579
|
Oyajobi BO and Mundy GR |
Receptor activator of NF-kappaB ligand, macrophage inflammatory protein-1alpha, and the proteasome: novel therapeutic targets in myeloma. |
2003 |
Cancer |
pmid:12548580
|
Liu JZ et al. |
[The OPG/RANKL/RANK system and bone resorptive disease]. |
2003 |
Sheng Wu Gong Cheng Xue Bao |
pmid:15971575
|
Liu JZ et al. |
[Construction and biological activity study of human osteoprotegerin expressing adenoviral system]. |
2003 |
Sheng Wu Gong Cheng Xue Bao |
pmid:15969033
|
Chagraoui H et al. |
Stimulation of osteoprotegerin production is responsible for osteosclerosis in mice overexpressing TPO. |
2003 |
Blood |
pmid:12506018
|
Lee Y et al. |
Differences in the cytokine profiles associated with prostate cancer cell induced osteoblastic and osteolytic lesions in bone. |
2003 |
J. Orthop. Res. |
pmid:12507581
|
Sabokbar A et al. |
Two distinct cellular mechanisms of osteoclast formation and bone resorption in periprosthetic osteolysis. |
2003 |
J. Orthop. Res. |
pmid:12507582
|
Elhasid R et al. |
Familial severe congenital neutropenia associated with infantile osteoporosis: a new entity. |
2003 |
Am. J. Hematol. |
pmid:12508266
|
Haynes DR et al. |
Osteoprotegerin expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathies and osteoarthritis and normal controls. |
2003 |
Rheumatology (Oxford) |
pmid:12509625
|